1-11 of 11
Authors: Vanan Magimairajan
Save search
Sort by
Journal Article

LGG-60. DISTRIBUTION AND CLINICAL SIGNIFICANCE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMAS

PDF
Liana Nobre and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.449
Published: 18 June 2024
Journal Article

MDB-09. WNT AND GROUP 4 MEDULLOBLASTOMAS OF EARLY CHILDHOOD TREATED WITH HIGH DOSE CHEMOTHERAPY AND CRANIOSPINAL IRRADIATION SPARING APPROACH

PDF
Rose Daynielle Cansanay and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.458
Published: 18 June 2024
Journal Article

BIOM-12. LIQUID BIOPSIES IN CNS TUMORS: A COMBINED APPROACH TO PROFILING CSF

PDF
Liana Nobre and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.031
Published: 18 June 2024
Journal Article

RADT-11. PROTON BEAM THERAPY (PBT) FOR CENTRAL NERVOUS SYSTEM (CNS) TUMOURS IN CHILDREN: A CANADIAN PEDIATRIC BRAIN TUMOUR CONSORTIUM STUDY

PDF
Kendrew S K Wong and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.771
Published: 18 June 2024
Journal Article

IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study

PDF
Anirban Das and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i84, https://doi.org/10.1093/neuonc/noac079.306
Published: 03 June 2022
Journal Article

IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY

PDF
Eric Bouffet and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii363, https://doi.org/10.1093/neuonc/noaa222.374
Published: 04 December 2020
Journal Article

HGG-20. DIAGNOSTIC AND BIOLOGICAL ROLE OF METHYLATION PATTERNS IN REPLICATION REPAIR DEFICIENT HIGH GRADE GLIOMAS

PDF
Andrew Dodgshun and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii347–iii348, https://doi.org/10.1093/neuonc/noaa222.307
Published: 04 December 2020
Journal Article

RARE-17. SURVIVAL BENEFIT FOR INDIVIDUALS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME AND BRAIN TUMORS WHO UNDERGO SURVEILLANCE PROTOCOL. A REPORT FROM THE INTERNATIONAL REPLICATION REPAIR CONSORTIUM

PDF
Ayse Bahar Ercan and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii445–iii446, https://doi.org/10.1093/neuonc/noaa222.728
Published: 04 December 2020
Journal Article

IMMU-20. IMMUNE AND TUMOR BIOMARKERS OF OUTCOME IN REPLICATION REPAIR DEFICIENT BRAIN TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: UPDATES FROM THE INTERNATIONAL REPLICATION REPAIR DEFICIENCY CONSORTIUM

PDF
Eric Bouffet and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Pages ii96–ii97, https://doi.org/10.1093/neuonc/noz036.139
Published: 23 April 2019
Journal Article

HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES

PDF
Andrew Dodgshun and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i92–i93, https://doi.org/10.1093/neuonc/noy059.292
Published: 22 June 2018
Journal Article

PDCT-09. HYPERMUTATION AND NEOANTIGEN FORMATION IS DIAGNOSTIC AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT BRAIN TUMORS

PDF
Brittany Campbell and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi147, https://doi.org/10.1093/neuonc/now212.613
Published: 07 November 2016